Maximilian Haist

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 14

Top Topics

Squamous Cell Carcinoma

Ejection Fraction

Top Venues

Journal of clinical medicine

International journal of environmental research and public health

Journal of thrombosis and haemostasis : JTH

This page only lists publications with an associated author ORCID identifier.

Publications

Henner Stege, Sara Schneider, Andrea Forschner, Thomas Eigentler, Dorothée Nashan, Svea Huening, Saskia Lehr, Frank Meiss, Martin Kaatz, Robert Kuchen, Katharina C Kaehler, Maximilian Haist, Stephan Grabbe, Jutta Huebner, Carmen Loquai
Second opinion and self-efficacy in German skin cancer patients. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG (2024)
Henner Stege, Maximilian Haist, Michael Schultheis, Johannes Pawlowski, Miriam Wittmann, Stephan Grabbe, Florian Butsch
Treatment of Lichen Planopilaris and Frontal Fibrosing Alopecia: A Retrospective, Real-Life Analysis in a Tertiary Center in Germany. Journal of clinical medicine 13 (16) (2024)
Henner Stege, Maximilian Haist, Michael Schultheis, Johannes Pawlowski, Miriam Wittmann, Stephan Grabbe, Florian Butsch
Treatment of Lichen Planopilaris and Frontal Fibrosing Alopecia: A Retrospective, Real-Life Analysis in a Tertiary Center in Germany. Journal of clinical medicine 13 (16) (2024)
Maximilian Haist, Henner Stege, Friederike Rogall, Yuqi Tan, Imke von Wasielewski, Kai Christian Klespe, Friedegund Meier, Peter Mohr, Katharina C Kähler, Michael Weichenthal, Axel Hauschild, Dirk Schadendorf, Selma Ugurel, Georg Lodde, Lisa Zimmer, Ralf Gutzmer, Dirk Debus, Bastian Schilling, Alexander Kreuter, Jens Ulrich, Frank Meiss, Rudolf Herbst, Andrea Forschner, Ulrike Leiter, Claudia Pfoehler, Martin Kaatz, Fabian Ziller, Jessica C Hassel, Michael Tronnier, Michael Sachse, Edgar Dippel, Patrick Terheyden, Carola Berking, Markus V Heppt, Felix Kiecker, Sebastian Haferkamp, Christoffer Gebhardt, Jan Christoph Simon, Stephan Grabbe, Carmen Loquai
Treatment management for BRAF -mutant melanoma patients with tumor recurrence on adjuvant therapy: a multicenter study from the prospective skin cancer registry ADOREG. Journal for immunotherapy of cancer 11 (9) (2023)
Maximilian Haist, Henner Stege, Michael Kuske, Julia Bauer, Annika Klumpp, Stephan Grabbe, Matthias Bros
Combination of immune-checkpoint inhibitors and targeted therapies for melanoma therapy: The more, the better? Cancer metastasis reviews (2023)
Monika Bednarczyk, Vanessa Bolduan, Maximilian Haist, Henner Stege, Christoph Hieber, Lisa Johann, Carsten Schelmbauer, Michaela Blanfeld, Khalad Karram, Jenny Schunke, Tanja Klaus, Ingrid Tubbe, Evelyn Montermann, Nadine Röhrig, Maike Hartmann, Jana Schlosser, Tobias Bopp, Björn E Clausen, Ari Waisman, Matthias Bros, Stephan Grabbe
β2 Integrins on Dendritic Cells Modulate Cytokine Signaling and Inflammation-Associated Gene Expression, and Are Required for Induction of Autoimmune Encephalomyelitis. Cells 11 (14) (2022)
Maximilian Haist, Henner Stege, Berenice Mareen Lang, Aikaterini Tsochataridou, Martin Salzmann, Peter Mohr, Dirk Schadendorf, Selma Ugurel, Jan-Malte Placke, Michael Weichenthal, Ralf Gutzmer, Ulrike Leiter, Martin Kaatz, Sebastian Haferkamp, Carola Berking, Markus Vincent Heppt, Barbara Tschechne, Patrick Schummer, Christoffer Gebhardt, Stephan Grabbe, Carmen Loquai
Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the German ADOReg Registry. Cancers 14 (22) (2022)
Maria Isabel Fleischer, Nadine Röhrig, Verena K Raker, Juliane Springer, Detlef Becker, Sandra Ritz, Matthias Bros, Henner Stege, Maximilian Haist, Stephan Grabbe, Jessica Haub, Christian Becker, Sabine Reyda, Jennifer Disse, Talkea Schmidt, Karsten Mahnke, Hartmut Weiler, Wolfram Ruf, Kerstin Steinbrink
Protease- and cell type-specific activation of protease-activated receptor 2 in cutaneous inflammation. Journal of thrombosis and haemostasis : JTH 20 (12) (2022)
Michael Kuske, Maximilian Haist, Thomas Jung, Stephan Grabbe, Matthias Bros
Immunomodulatory Properties of Immune Checkpoint Inhibitors-More than Boosting T-Cell Responses? Cancers 14 (7) (2022)
Maximilian Haist, Henner Stege, Ronja Ebner, Maria Isabel Fleischer, Carmen Loquai, Stephan Grabbe
The Role of Treatment Sequencing with Immune-Checkpoint Inhibitors and BRAF/MEK Inhibitors for Response and Survival of Patients with BRAFV600-Mutant Metastatic Melanoma-A Retrospective, Real-World Cohort Study. Cancers 14 (9) (2022)
Henner Stege, Sara Schneider, Andrea Forschner, Thomas Kurt Eigentler, Dorothée Nashan, Svea Huening, Frank Meiss, Saskia Lehr, Martin Kaatz, Robert Kuchen, Katharina C Kaehler, Maximilian Haist, Jutta Huebner, Carmen Loquai
eHealth Literacy in German Skin Cancer Patients. International journal of environmental research and public health 19 (14) (2022)
Henner Stege, Maximilian Haist, Michael Schultheis, Maria Isabel Fleischer, Peter Mohr, Friedegund Meier, Dirk Schadendorf, Selma Ugurel, Elisabeth Livingstone, Lisa Zimmer, Rudolf Herbst, Claudia Pföhler, Katharina Kähler, Michael Weichenthal, Patrick Terheyden, Dorothée Nashan, Dirk Debus, Martin Kaatz, Fabian Ziller, Sebastian Haferkamp, Andrea Forschner, Ulrike Leiter, Alexander Kreuter, Jens Ulrich, Johannes Kleemann, Fabienne Bradfisch, Stephan Grabbe, Carmen Loquai
Discontinuation of BRAF/MEK-Directed Targeted Therapy after Complete Remission of Metastatic Melanoma-A Retrospective Multicenter ADOReg Study. Cancers 13 (10) (2021)
Thomas Jung, Maximilian Haist, Michael Kuske, Stephan Grabbe, Matthias Bros
Immunomodulatory Properties of BRAF and MEK Inhibitors Used for Melanoma Therapy-Paradoxical ERK Activation and Beyond. International journal of molecular sciences 22 (18) (2021)
Maximilian Haist, Henner Stege, Saskia Pemler, Jaqueline Heinz, Maria Isabel Fleischer, Claudine Graf, Wolfram Ruf, Carmen Loquai, Stephan Grabbe
Anticoagulation with Factor Xa Inhibitors Is Associated with Improved Overall Response and Progression-Free Survival in Patients with Metastatic Malignant Melanoma Receiving Immune Checkpoint Inhibitors-A Retrospective, Real-World Cohort Study. Cancers 13 (20) (2021)